T. Gajewski

发表

From defined human tumor antigens to effective immunization?

P. Coulie, T. Boon, T. Gajewski, 1995, Immunology today.

Costimulation with B7-1, IL-6, and IL-12 is sufficient for primary generation of murine antitumor cytolytic T lymphocytes in vitro.

J. Renauld, T. Boon, A. van Pel, 1995, Journal of immunology.

B7-1 but not B7-2 efficiently costimulates CD8+ T lymphocytes in the P815 tumor system in vitro.

T. Gajewski, 1996, Journal of immunology.

Antigen-specific regression of established tumors induced by active immunization with irradiated IL-12- but not B7-1-transfected tumor cells.

T. Boon, F. Fallarino, A. Ashikari, 1997, International Immunology.

Non-redundant Requirement for CXCR3 Signaling during Tumoricidal T Cell Trafficking across Tumor Vascular Checkpoints

K. Odunsi, J. Skitzki, A. Luster, 2015, Nature Communications.

Tumor rejection requires a CTLA4 ligand provided by the host or expressed on the tumor: superiority of B7-1 over B7-2 for active tumor immunization.

C. Uyttenhove, T. Boon, F. Fallarino, 1996, Journal of immunology.

Endogenous IL-12 is necessary for rejection of P815 tumor variants in vivo.

C. Uyttenhove, T. Boon, F. Fallarino, 1996, Journal of immunology.

Differential regulation of murine T lymphocyte subsets.

D. Lancki, T. Gajewski, F. Fitch, 1993, Annual review of immunology.